Skip to content
Monday 16 Nov 2026 · Kabul 12:41 PM
13° — weather in every province
Clear · ↑14° ↓0°
Air quality: moderate
Section

Health

3,465 stories

Stories

MoPH warns returnees, low public awareness increasing hepatitis risk

Marking World Hepatitis Day, the Ministry of Public Health (MoPH) says more than 27,800 positive cases of hepatitis B and C have been recorded across Afghanistan since the beginning of 2026, warning that the return of migrants and low public awareness are increasing the risk of the disease spreading.

$2.6m healthcare project to launch in Badakhshan, Baghlan

The Ministry of Public Health has signed a $2.6 million agreement with the Aga Khan Foundation (AKF) to implement a programme aimed at reducing child stunting, improving nutrition and lowering low birth-weight cases in Badakhshan and Baghlan provinces.

MoPH, AHDS sign $3m maternal healthcare deal

The Ministry of Public Health (MoPH) and Afghanistan Health and Development Services (AHDS) have signed a contract worth more than $3 million to provide maternal healthcare services in four provinces.

Kabul, Tashkent discuss health sector cooperation

Afghan and Uzbek officials have discussed expanding health sector cooperation, including treatment of Afghan patients, pharmaceutical development and medical equipment production, the Ministry of Public Health said on Saturday.

MoPH launches free eye care campaign in Ghor

The Ministry of Public Health (MoPH) has launched a free eye care campaign in western Ghor province, offering 400 cataract surgeries, 1,000 reading glasses and treatment for thousands of eye patients.

US restricts direct return of citizens from DR Congo over Ebola outbreak

The Trump administration has announced that, in response to the expanding Ebola outbreak in the Democratic Republic of the Congo (DRC), US citizens currently in the country will not be permitted to travel directly to the United States on commercial flights until further notice.

WHO urges faster polio eradication efforts in Afghanistan

The World Health Organization (WHO) has called for accelerated efforts to eradicate polio in Afghanistan, expand children’s access to vaccines, and strengthen health services in the country following the conclusion of a high-level delegation’s visit. In a statement…

Mobile eye care team deployed to Baghlan: MoPH

The Ministry of Public Health (MoPH) has announced the deployment of a mobile eye care team to Baghlan province, saying it will provide free surgeries, examinations, eyeglasses and medicines to patients in need.

Opium production in Afghanistan falls by 95pc since 2023: UNODC

The United Nations Office on Drugs and Crime (UNODC) says opium production in Afghanistan has declined by 95 percent since 2023, significantly affecting the global illicit opiates market. UNODC, in its World Drug Report 2026, said the unprecedented…

World Blood Donor Day: Growing need for blood in Afghanistan

Coinciding with World Blood Donor Day, officials at the Central Blood Bank say the demand for blood in the country is increasing due to a rise in thalassemia patients, Congo fever cases and victims of accidents. Meanwhile, patients dependent on blood describe donors’ role as vital to saving their lives.

120 Congo fever cases recorded in Kabul hospital in 15 days

A specialist in infectious diseases at the National and Specialized Antani Hospital in Kabul says that 120 patients infected with Congo fever have been registered at the hospital in the past 15 days, while 150 cases had been recorded from the beginning of the current year until one day before Eid al-Adha.

Jalali, WHO chief discuss strengthening health programs

Afghanistan’s Minister of Public Health, Mawlawi Noor Jalal Jalali, and the World Health Organization (WHO) Representative for Afghanistan, Dr. Edwin Ceniza Salvador, have discussed strengthening health programmes, including polio laboratory operations and the implementation of new health initiatives.…

Study finds daraxonrasib boosts survival in pancreatic cancer

American scientists have found in a new study that the oral drug daraxonrasib can nearly double the survival time of patients with advanced pancreatic cancer, a result being described as one of the most promising developments in the treatment of the disease.

Show more stories